Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Limited
TEVA
Valuace
0
Růst
40
Zdraví
57
Cena
$ 24.30
Dnes
--0.59 (-1.82%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
27.9B
Obrat
17B
Zisk
1B
Aktiva
40B
Dluh
18B
ROE
0%
ROA
0%
PE
24
PS
2
Cena 1R
12-33
⌀ Cena
20.19
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
04-02-2026
Poslední dividenda

Profil

Teva Pharmaceutical Industries Limited, farmaceutická společnost, vyvíjí, vyrábí, prodává a distribuuje generická léčiva, speciální léčiva a biofarmaceutické produkty v Severní Americe, Evropě a mezinárodně. Společnost nabízí sterilní produkty, hormony, vysoce účinné léky a cytotoxické látky v různých formách dávkování, včetně tablet, tobolek, injekčních tablet, inhalantů, tekutin, transdermálních náplastí, mastí a krémů. Rovněž vyvíjí, vyrábí a prodává aktivní farmaceutické složky. Kromě toho se zaměřuje na centrální nervový systém, bolest, respirační a onkologické oblasti. Jeho produkty v centrální nervové soustavě zahrnují Copaxon pro léčbu relabujících forem roztroušené sklerózy, AJOVY pro preventivní léčbu migrény a AUSTEDO pro léčbu tardivní dyskineze a chorey spojené s Huntingtonovou chorobou. Mezi produkty společnosti na trhu s dýcháním patří ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler a ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax a AirDuo RespiClick/ArmonAir RespiClick pro léčbu astmatu a chronické obstrukční plicní nemoci. Mezi jeho produkty na onkologickém trhu patří Bendeka, Treanda, Granix, Trisenox, Lonquex a Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited spolupracuje s MedinCell na vývoji a komercializaci mnoha dlouhodobě působících injekčních přípravků, suspenze risperidonu pro léčbu pacientů se schizofrenií. Společnost byla založena v roce 1901 a sídlí v Tel Aviv-Yafo v Izraeli.
Sektor
Healthcare
Odvětví
Drug Manufacturers - Specialty & Generic
Počet zaměstnanců
37000
Založení
1982-02-16
Adresa
124 Dvora Hanevi'a Street
CEO
Richard D. Francis

Podobné společnosti

$ 155.44
- $ 0.07
$ 261.57
- $ 2.21
$ 54.68
- $ 0.32
$ 105.10
+ $ 1.96
$ 205.56
+ $ 5.99
$ 317.87
- $ 1.95
$ 253.84
+ $ 1.12

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliardách (USD)
Revenue TTM 2025202420232022202120202019201820172016201520142013201220112010
Total Revenues17.2617.2616.5415.8514.9315.8816.6616.8918.8522.3921.9019.6520.2720.3120.3218.3116.12
Cost of Revenues8.328.328.488.207.958.288.939.3510.5611.5610.048.309.229.619.678.807.06
Gross Profit8.948.948.067.656.977.597.737.548.3010.8311.8611.3611.0610.7110.659.529.07
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues4.714.484.183.894.234.334.163.824.463.85
Cost of Revenues2.062.182.072.012.112.182.142.052.042.00
Gross Profit2.662.302.101.882.122.152.021.772.421.85
Operating Income TTM 2025202420232022202120202019201820172016201520142013201220112010
R&D Expenses0.000.000.000.950.840.971.001.011.211.852.111.531.491.431.361.100.93
Selling General & Admin Expenses0.000.000.003.503.453.533.673.814.214.995.104.725.085.325.124.413.83
Depreciation & Amortization1.001.001.061.151.311.331.560.421.842.111.521.311.511.641.711.070.98
Total Operating Expenses6.786.788.374.454.284.504.674.825.436.837.216.246.576.756.475.514.77
Operating Income2.162.16-0.300.432.803.203.052.80-1.64-17.482.153.353.951.652.213.113.87
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.000.000.000.000.000.000.000.000.230.25
Selling General & Admin Expenses0.000.000.000.000.000.000.000.000.900.84
Depreciation & Amortization0.260.250.250.240.270.260.260.270.270.28
Total Operating Expenses2.361.421.651.362.152.202.031.991.131.10
Operating Income0.300.880.460.52-0.03-0.05-0.01-0.220.720.36
Net Income TTM 2025202420232022202120202019201820172016201520142013201220112010
Interest Income0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Interest Expense0.930.920.940.000.971.060.960.820.960.901.331.000.310.400.360.150.23
Other Expense-0.92-0.92-0.98-1.06-5.86-2.54-7.46-4.06-4.51-21.48-2.50-1.76-0.54-2.31-1.97-0.90-0.43
IBT1.241.24-1.28-0.62-3.070.66-4.41-1.27-2.60-18.380.822.353.641.251.822.963.65
Income Tax Expense-0.18-0.180.68-0.01-0.640.21-0.17-0.28-0.20-1.930.520.630.59-0.04-0.140.130.28
Net Income1.411.41-1.64-0.56-2.350.42-3.99-1.00-2.15-16.270.331.593.061.271.962.763.33
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income0.000.000.000.000.000.000.000.000.000.00
Interest Expense0.290.210.200.23-0.760.270.240.250.260.28
Other Expense-0.21-0.23-0.25-0.23-0.22-0.27-0.24-0.25-0.25-0.28
IBT0.090.650.200.29-0.25-0.32-0.24-0.470.470.08
Income Tax Expense-0.390.21-0.080.070.030.070.63-0.050.04-0.01
Net Income0.480.430.280.21-0.22-0.44-0.85-0.140.430.08
Per Share Data TTM 2025202420232022202120202019201820172016201520142013201220112010
EPS$0.00$0.00$0.00$-0.50$-2.12$0.38$-3.64$-0.92$-2.11$-16.01$0.07$1.84$3.58$1.49$2.25$3.10$3.72
EPS Diluted$0.00$0.00$0.00$-0.50$-2.12$0.38$-3.64$-0.92$-2.11$-16.01$0.07$1.82$3.56$1.49$2.25$3.09$3.67
Shares Outstanding1.151.151.131.121.111.101.101.091.021.020.960.860.850.850.870.890.90
Diluted Shares Outstanding1.171.171.131.121.111.111.101.091.021.020.960.860.860.850.870.890.92
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.41$0.07
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.41$0.07
Shares Outstanding1.151.151.151.141.131.131.131.121.121.12
Diluted Shares Outstanding1.171.161.161.161.131.131.131.121.141.14
Current Assets TTM 202420232022202120202019201820172016201520142013201220112010
Cash And Equivalents2.263.303.232.802.172.181.981.780.960.996.952.231.042.881.101.25
Short Term Investments0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.04
Total Cash & ST Investments2.263.303.232.802.172.181.981.780.960.996.952.231.042.881.101.28
Accounts Receivable3.773.063.413.704.534.585.685.827.137.525.355.415.345.576.215.48
Inventory3.933.014.023.833.824.404.424.734.924.953.974.375.055.505.013.87
Other Current Assets1.683.191.830.550.970.710.430.470.701.291.401.401.211.262.131.42
Total Current Assets11.6312.5512.4912.0512.5713.0113.4613.7915.3816.9618.4014.4013.7216.3614.4512.24
Current Assets 2-20251-20254-20243-20242-20241-20244-20233-20232-20231-2023
Cash And Equivalents2.161.703.303.322.262.993.232.252.672.14
Short Term Investments0.000.000.000.000.000.000.000.000.000.00
Total Cash & ST Investments2.161.703.303.322.262.993.232.252.672.14
Accounts Receivable3.563.383.063.463.773.463.413.393.543.44
Inventory3.503.253.013.963.933.954.024.054.114.12
Other Current Assets3.403.203.191.571.681.901.831.741.771.81
Total Current Assets12.6211.5312.5512.3111.6312.3012.4911.4312.0911.50
Long-Term Assets TTM 202420232022202120202019201820172016201520142013201220112010
Net Property, Plant & Equipment5.934.956.156.166.486.856.956.877.678.076.546.546.646.325.954.36
Goodwill16.4915.1517.1817.6320.0420.6224.8524.9228.4144.4119.0318.4118.9818.8618.2915.23
Intangible Assets4.854.425.396.277.478.9211.2314.0117.6421.497.685.516.487.7510.325.75
Long-Term Investments0.000.000.010.000.000.000.000.000.000.000.000.000.000.000.990.63
Other Long-Term Assets0.430.460.460.440.520.540.590.730.931.242.621.571.701.340.000.00
Total Long-Term Assets29.7126.7730.9931.9635.0937.6344.0146.8955.2375.9335.8632.0233.7934.2535.6926.81
Total Assets41.3439.3343.4844.0147.6750.6457.4760.6870.6292.8954.2646.4247.5150.6150.1439.05
Long-Term Assets 2-20251-20254-20243-20242-20241-20244-20233-20232-20231-2023
Net Property, Plant & Equipment5.174.994.956.045.935.986.156.036.136.17
Goodwill15.9515.4815.1516.1216.4917.0117.1816.8917.1217.80
Intangible Assets4.144.194.424.764.855.065.395.535.745.96
Long-Term Investments0.000.000.000.000.000.000.010.000.010.00
Other Long-Term Assets0.470.460.460.460.430.470.460.480.430.45
Total Long-Term Assets27.5126.8926.7729.4529.7130.4830.9930.6631.0131.96
Total Assets40.1338.4239.3341.7641.3442.7743.4842.0943.1043.46
Current Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Accounts Payable2.372.202.601.891.691.761.721.852.072.169.468.037.157.171.131.18
Short-Term Debt2.091.871.672.111.433.192.352.223.653.281.591.761.803.014.281.43
Other Current Liabilities8.588.737.976.020.900.930.890.800.7612.361.231.511.931.575.825.94
Current Liabilities13.0412.8012.2511.4711.0313.1613.6714.3217.9218.5213.0112.2911.9712.8913.859.89
Current Liabilities 2-20251-20254-20243-20242-20241-20244-20233-20232-20231-2023
Accounts Payable2.502.292.202.372.372.442.602.282.512.38
Short-Term Debt0.460.421.782.582.093.061.771.481.981.02
Other Current Liabilities8.908.458.818.858.588.297.887.647.367.01
Current Liabilities11.8611.1612.8013.8013.0413.7912.2511.3911.8410.41
Long-Term Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Long-Term Debt16.5516.3018.4819.4522.0323.2125.0026.7028.8332.528.388.5710.3911.7110.244.10
Capital Leases0.280.300.320.350.420.480.440.000.000.000.000.000.000.000.000.00
Def. Tax Liability0.550.480.610.550.780.961.102.143.285.221.751.101.251.852.612.05
Total Liabilities34.7733.6135.3535.3236.4239.5842.4144.8951.8757.9024.3323.0724.8727.7427.8017.05
Long-Term Liabilities 2-20251-20254-20243-20242-20241-20244-20233-20232-20231-2023
Long-Term Debt17.0616.5216.3016.7016.8316.8818.4818.8219.0420.01
Capital Leases0.300.290.300.300.280.290.320.320.340.35
Def. Tax Liability0.440.460.480.540.550.570.610.540.530.55
Total Liabilities33.3032.1533.6135.3734.7835.2335.3534.5835.3934.85
Total Common Equity TTM 202420232022202120202019201820172016201520142013201220112010
Common Stock0.060.060.060.060.060.060.060.060.050.050.050.050.050.050.050.05
Retained Earnings-14.52-15.17-13.53-12.88-10.53-10.95-6.96-5.96-3.8013.6114.8514.4412.5412.3511.289.33
Comprehensive Income-2.88-3.15-2.70-2.84-2.68-2.40-2.31-2.46-1.85-3.16-1.96-1.34-0.09-0.02-0.590.35
Total Common Equity6.365.377.517.9010.2810.0313.9714.7117.3633.3429.7723.3122.5722.7722.2021.95
Total Common Equity 2-20251-20254-20243-20242-20241-20244-20233-20232-20231-2023
Common Stock0.060.060.060.060.060.060.060.060.060.06
Retained Earnings-14.68-14.96-15.17-14.96-14.52-13.67-13.53-13.87-13.95-13.09
Comprehensive Income-2.43-2.68-3.15-2.77-2.88-2.78-2.70-2.91-2.68-2.70
Total Common Equity6.836.265.376.076.367.287.516.937.057.86
Other TTM 202420232022202120202019201820172016201520142013201220112010
Total Debt18.9218.0820.1521.5623.4626.4027.3428.9232.4835.809.9710.3312.1914.7214.525.53
Book Value6.565.728.138.6911.2411.0615.0615.7918.7534.9929.9323.3622.6422.8722.3422.00
Other 2-20251-20254-20243-20242-20241-20244-20233-20232-20231-2023
Total Debt0.010.010.350.320.200.270.620.580.660.75
Book Value6.836.265.376.076.367.287.516.937.057.86
Cash Flow From Operating Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Income-0.461.42-1.65-0.62-2.410.46-4.100.08-2.47-16.450.311.603.041.251.912.773.34
Depreciation & Amortization1.081.001.061.151.311.331.560.421.842.111.521.311.511.641.711.070.98
Stock-Based Compensation0.120.160.000.120.120.120.130.020.160.130.120.120.100.060.080.090.08
Change Working Capital-0.42-1.37-0.44-0.071.26-1.70-2.19-0.11-1.82-0.361.220.970.290.970.410.60-0.25
Change In Accounts Receivable1.40-0.170.000.010.33-0.57-0.29-0.390.090.510.340.760.710.090.940.00-0.36
Change In Accounts Payable0.47-0.020.001.591.910.76-0.460.64-0.50-1.800.64-0.01-0.610.38-0.020.54-0.30
Change In Inventories-0.150.150.000.00-0.160.380.040.270.030.270.750.130.230.40-0.45-0.41-0.02
Other Non-cash Items3.371.114.211.102.370.716.510.475.5820.412.031.320.420.691.150.110.19
Cash from Operations1.780.000.001.371.590.801.220.542.453.515.235.545.133.244.574.134.14
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income0.480.430.280.22-0.22-0.39-0.87-0.420.430.09
Depreciation & Amortization0.260.250.250.240.270.260.260.270.270.28
Stock-Based Compensation0.050.030.040.030.000.030.030.030.030.03
Change Working Capital0.23-0.56-0.34-0.70-0.250.32-0.01-0.500.33-0.24
Change In Accounts Receivable0.000.000.000.000.000.000.000.000.420.36
Change In Accounts Payable0.000.000.000.000.000.000.000.000.470.00
Change In Inventories0.000.000.000.000.000.000.000.00-0.150.00
Other Non-cash Items0.730.110.200.071.080.531.120.680.100.04
Cash from Operations0.000.000.000.000.000.000.000.001.180.01
Cash Flow From Investing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Capital Expenditure-0.49-0.50-0.50-0.53-0.55-0.56-0.58-0.12-0.65-0.87-0.90-0.77-0.93-1.03-1.10-1.05-0.71
Acquisitions-0.140.03-0.080.070.061.960.00-0.341.740.04-36.15-3.31-0.36-0.040.00-6.56-4.95
Investments-0.10-0.060.00-0.050.00-0.05-0.060.00-0.12-0.20-0.48-2.00-0.32-0.16-0.20-0.22-0.44
Sales of Investment-0.370.040.040.000.000.170.000.340.893.482.000.520.200.190.007.830.61
Other Investing Activities0.740.000.001.471.140.001.500.550.013.201.790.520.170.080.170.230.03
Cash from Investing0.130.000.000.970.661.520.860.431.872.16-35.74-5.57-1.45-1.15-1.13-7.60-5.46
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-0.14-0.14-0.10-0.13-0.13-0.15-0.10-0.12-0.12-0.15
Acquisitions0.000.010.010.020.000.040.00-0.02-0.070.01
Investments-0.02-0.01-0.02-0.010.000.00-0.04-0.010.00-0.04
Sales of Investment0.040.000.000.000.000.040.000.00-0.36-0.01
Other Investing Activities0.000.000.000.000.000.000.000.000.420.37
Cash from Investing0.000.000.000.000.000.000.000.000.300.18
Cash Flow From Financing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Debt Repaid-2.660.000.00-1.70-1.37-7.84-2.43-2.23-7.45-3.30-1.00-2.52-0.84-3.13-2.21-1.57-2.89
Debt Issued0.5618.08-2.070.29-0.534.901.490.663.89-0.0326.832.16-1.030.612.4210.558.42
Issuance of Common Stock0.000.000.000.000.000.000.000.000.000.000.333.290.130.812.553.263.66
Repurchase of Common Stock0.000.000.000.000.000.000.000.000.000.0027.61-0.44-0.50-0.50-1.16-0.90-0.10
Dividends Paid0.000.000.000.000.000.000.00-0.05-0.02-1.16-1.56-1.16-1.16-1.09-0.86-0.80-0.67
Other Financing Activities0.450.000.00-0.21-0.125.670.552.044.12-1.2927.455.630.120.842.556.604.23
Cash from Financing-2.210.000.00-1.91-1.49-2.17-1.89-0.24-3.35-5.7525.224.81-2.38-3.88-1.683.340.57
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.000.000.000.000.000.000.000.00-0.50-0.50
Debt Issued0.0017.520.58-1.14-1.200.35-1.02-0.220.35-0.22
Issuance of Common Stock0.000.000.000.000.000.000.000.000.000.00
Repurchase of Common Stock0.000.000.000.000.000.000.000.000.000.00
Dividends Paid0.000.000.000.000.000.000.000.000.000.00
Other Financing Activities0.000.000.000.000.000.000.000.00-0.08-0.08
Cash from Financing0.000.000.000.000.000.000.000.00-0.58-0.58
Cash position TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Change in Cash-0.410.260.070.390.640.020.200.730.82-0.03-5.964.721.19-1.841.78-0.15-0.75
Closing Cash Balance2.263.563.303.232.832.202.181.981.780.960.996.952.231.042.881.101.25
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash1.350.040.46-1.60-0.021.06-0.73-0.240.98-0.42
Closing Cash Balance3.562.202.161.703.303.322.262.993.232.25
Free Cash Flow TTM 2025202420232022202120202019201820172016201520142013201220112010
Free Cash Flow1.291.152.050.841.040.240.640.421.802.634.324.774.202.213.473.083.43
Real Free Cash Flow1.170.992.050.720.920.120.510.401.642.504.204.654.102.143.392.993.35
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow1.020.230.13-0.230.790.550.01-0.251.07-0.14
Real Free Cash Flow0.970.200.09-0.270.790.52-0.03-0.281.04-0.18
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E23.948.92356.8
P/S21.870.5
P/B4.91.62015.4
P/FCF3468.47573.5
Market cap$27.9$23.6
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets0 %35.6 %0 %
Debt to Income1243.6 %8267.4 %0 %
Debt to Free cash flow1768.2 %15.6 %0 %
Interest expense percentage43.1 %13.6 %26.2 %
Current ratio1.1 1.1 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE20.6 %-9 %0 %
ROA3.5 %-0.9 %0 %
CapEx to Revenue2.9 %3.8 %6 %
RaD to Revenue0 %6.5 %0 %
ROEM468,585.4 208898.9

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin51.8 %50.4 %74.8 %
Operating margin12.5 %2.6 %35 %
Net margin8.2 %-3.5 %34.1 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %1.4 %0 %
Dividend payout percentage0 %33.2 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding1,173.0 mil 1,005.0 mil
Employee count36.8 tis 34.2 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader